Invesco’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Invesco’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-430,348	Closed	-$8.68M	–	4145
2021 Q3	$8.68M	Buy	430,348 +240,293	+126%	+$6.63M	﹤0.01%	2080
2021 Q2	$7.09M	Sell	190,055 -100,830	-35%	-$3.09M	﹤0.01%	2261
2021 Q1	$7.44M	Sell	290,885 -4,849	-2%	-$124K	﹤0.01%	2143
2020 Q4	$6.51M	Sell	295,734 -55,078	-16%	-$1.21M	﹤0.01%	2050
2020 Q3	$6.31M	Sell	350,812 -13,542	-4%	-$280K	﹤0.01%	1889
2020 Q2	$9.26M	Sell	364,354 -121,871	-25%	-$2.63M	﹤0.01%	1672
2020 Q1	$8.93M	Buy	486,225 +443,858	+1,048%	+$8.63M	﹤0.01%	1587
2019 Q4	$934K	Buy	+42,367	New	+$853K	﹤0.01%	3029
2019 Q1	–	Sell	-141,438	Closed	-$1.51M	–	3881
2018 Q4	$1.51M	Buy	+141,438	New	+$1.86M	﹤0.01%	2732
2015 Q3	–	Sell	-368	Closed	-$5K	–	4089
2015 Q2	$5K	Sell	368 -62,571	-99%	-$1.15M	﹤0.01%	4241
2015 Q1	$1.51M	Buy	+62,939	New	+$1.42M	﹤0.01%	2796

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Invesco's DRNA Position: Q4 2021 in Review

Invesco sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 430,348 shares — an estimated $8.68M sold.

Invesco first reported a position in DRNA in Q1 2015 and held it in 11 quarters. The position peaked at $9.26M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Invesco reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Invesco sold 430,348 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $8.68M.
Invesco first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Invesco's Dicerna Pharmaceuticals, Inc. position peaked at $9.26M in Q2 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.